Global (United States, European Union and China) Occlusion Devices

Occlusion Devices Comprehensive Study by Type (Occlusion Balloon, Stent Retriever, Suction Device, Coil Embolization, Liquid Embolics), Application (Cardiology, Neurology, Peripheral Vascular, Urology, Oncology, Gyno), End-user (Hospitals, Diagnostic Centers & Surgical Centers, ACCs, Research Laboratories, Academic Institutes) Players and Region - Global Market Outlook to 2028

Occlusion Devices Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Occlusion Devices Market?

Occlusion devices are the devices used for treating cardiovascular defects, neurological defects, retinal defects, and others. Increased prevalence of cardiac diseases, increased number of diagnostic centers and hospitals, favorable reimbursement scenario for minimally invasive surgeries are the key driving factors for the occlusion devices market. Additionally, clinical evidence for the safety and efficacy of occlusion devices fueling the market growth. However, less awareness about the safety and efficacy of occlusion devices in some regions and lack of healthcare infrastructure in underdeveloped regions may hinder the market growth.

Highlights from Occlusion Devices Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledAbbott Laboratories (United States), Boston Scientific (United States), Cardinal Health (United States), Asahi Intecc (Japan), Avinger (United States), Medtronic (Ireland), Terumo Corporation (Japan), Stryker Corporation (United States), Penumbra (United States), B. Braun (Germany) and C.R. Bard (United States)


There are various companies that are operating in the new geographical regions by adopting various market growth initiatives such as mergers & acquisitions, expansions, investments, and others. There are various new market players are entering the market to capture market growth opportunities. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Occlusion Devices market throughout the forecasted period.

Abbott Laboratories (United States), Boston Scientific (United States), Cardinal Health (United States), Asahi Intecc (Japan), Avinger (United States), Medtronic (Ireland), Terumo Corporation (Japan), Stryker Corporation (United States), Penumbra (United States), B. Braun (Germany) and C.R. Bard (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Cook Group (United States), Edwards Lifesciences (United States) and AngioDynamics, Inc. (United States).

Occlusion Devices Market Segmentation:
ScopeSub-Segments
Application / End UserCardiology, Neurology, Peripheral Vascular, Urology, Oncology and Gyno
TypeOcclusion Balloon, Stent Retriever, Suction Device, Coil Embolization and Liquid Embolics
End-userHospitals,Diagnostic Centers & Surgical Centers,ACCs,Research Laboratories,Academic Institutes


On the basis of geography, the market of Occlusion Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technological Advancements in The Medical Science

Market Growth Drivers:
Increased Prevalence of Cardiovascular Diseases among People and Rise in the Number of Diagnostic Centres and Hospitals in Developing Regions

Challenges:
Lak of Healthcare Infrastructure in Underdeveloped Countries

Restraints:
Complications Associated with Surgery and Less Awareness about Safety and Efficacy of Occlusion Devices among People

Opportunities:
Growth in the Healthcare Sector Worldwide and Robust Increase in the Distribution Channels

Key Target Audience
Occlusion Devices Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users

In August 2019, Boston Scientific Corporation has announced the completion of its acquisition of BTG plc. pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals.


Report Objectives / Segmentation Covered

By Type
  • Occlusion Balloon
  • Stent Retriever
  • Suction Device
  • Coil Embolization
  • Liquid Embolics
By Application
  • Cardiology
  • Neurology
  • Peripheral Vascular
  • Urology
  • Oncology
  • Gyno
By End-user
  • Hospitals
  • Diagnostic Centers & Surgical Centers
  • ACCs
  • Research Laboratories
  • Academic Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Cardiovascular Diseases among People
      • 3.2.2. Rise in the Number of Diagnostic Centres and Hospitals in Developing Regions
    • 3.3. Market Challenges
      • 3.3.1. Lak of Healthcare Infrastructure in Underdeveloped Countries
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in The Medical Science
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Occlusion Devices, by Type, Application, End-user and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Occlusion Devices (Value)
      • 5.2.1. Global Occlusion Devices by: Type (Value)
        • 5.2.1.1. Occlusion Balloon
        • 5.2.1.2. Stent Retriever
        • 5.2.1.3. Suction Device
        • 5.2.1.4. Coil Embolization
        • 5.2.1.5. Liquid Embolics
      • 5.2.2. Global Occlusion Devices by: Application (Value)
        • 5.2.2.1. Cardiology
        • 5.2.2.2. Neurology
        • 5.2.2.3. Peripheral Vascular
        • 5.2.2.4. Urology
        • 5.2.2.5. Oncology
        • 5.2.2.6. Gyno
      • 5.2.3. Global Occlusion Devices by: End-user (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Diagnostic Centers & Surgical Centers
        • 5.2.3.3. ACCs
        • 5.2.3.4. Research Laboratories
        • 5.2.3.5. Academic Institutes
      • 5.2.4. Global Occlusion Devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Occlusion Devices (Volume)
      • 5.3.1. Global Occlusion Devices by: Type (Volume)
        • 5.3.1.1. Occlusion Balloon
        • 5.3.1.2. Stent Retriever
        • 5.3.1.3. Suction Device
        • 5.3.1.4. Coil Embolization
        • 5.3.1.5. Liquid Embolics
      • 5.3.2. Global Occlusion Devices by: Application (Volume)
        • 5.3.2.1. Cardiology
        • 5.3.2.2. Neurology
        • 5.3.2.3. Peripheral Vascular
        • 5.3.2.4. Urology
        • 5.3.2.5. Oncology
        • 5.3.2.6. Gyno
      • 5.3.3. Global Occlusion Devices by: End-user (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Diagnostic Centers & Surgical Centers
        • 5.3.3.3. ACCs
        • 5.3.3.4. Research Laboratories
        • 5.3.3.5. Academic Institutes
      • 5.3.4. Global Occlusion Devices Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Occlusion Devices (Price)
      • 5.4.1. Global Occlusion Devices by: Type (Price)
  • 6. Occlusion Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cardinal Health (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Asahi Intecc (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Avinger (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medtronic (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Terumo Corporation (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Stryker Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Penumbra (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. B. Braun (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. C.R. Bard (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Occlusion Devices Sale, by Type, Application, End-user and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Occlusion Devices (Value)
      • 7.2.1. Global Occlusion Devices by: Type (Value)
        • 7.2.1.1. Occlusion Balloon
        • 7.2.1.2. Stent Retriever
        • 7.2.1.3. Suction Device
        • 7.2.1.4. Coil Embolization
        • 7.2.1.5. Liquid Embolics
      • 7.2.2. Global Occlusion Devices by: Application (Value)
        • 7.2.2.1. Cardiology
        • 7.2.2.2. Neurology
        • 7.2.2.3. Peripheral Vascular
        • 7.2.2.4. Urology
        • 7.2.2.5. Oncology
        • 7.2.2.6. Gyno
      • 7.2.3. Global Occlusion Devices by: End-user (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Diagnostic Centers & Surgical Centers
        • 7.2.3.3. ACCs
        • 7.2.3.4. Research Laboratories
        • 7.2.3.5. Academic Institutes
      • 7.2.4. Global Occlusion Devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Occlusion Devices (Volume)
      • 7.3.1. Global Occlusion Devices by: Type (Volume)
        • 7.3.1.1. Occlusion Balloon
        • 7.3.1.2. Stent Retriever
        • 7.3.1.3. Suction Device
        • 7.3.1.4. Coil Embolization
        • 7.3.1.5. Liquid Embolics
      • 7.3.2. Global Occlusion Devices by: Application (Volume)
        • 7.3.2.1. Cardiology
        • 7.3.2.2. Neurology
        • 7.3.2.3. Peripheral Vascular
        • 7.3.2.4. Urology
        • 7.3.2.5. Oncology
        • 7.3.2.6. Gyno
      • 7.3.3. Global Occlusion Devices by: End-user (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Diagnostic Centers & Surgical Centers
        • 7.3.3.3. ACCs
        • 7.3.3.4. Research Laboratories
        • 7.3.3.5. Academic Institutes
      • 7.3.4. Global Occlusion Devices Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Occlusion Devices (Price)
      • 7.4.1. Global Occlusion Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Occlusion Devices: by Type(USD Million)
  • Table 2. Occlusion Devices Occlusion Balloon , by Region USD Million (2017-2022)
  • Table 3. Occlusion Devices Stent Retriever , by Region USD Million (2017-2022)
  • Table 4. Occlusion Devices Suction Device , by Region USD Million (2017-2022)
  • Table 5. Occlusion Devices Coil Embolization , by Region USD Million (2017-2022)
  • Table 6. Occlusion Devices Liquid Embolics , by Region USD Million (2017-2022)
  • Table 7. Occlusion Devices: by Application(USD Million)
  • Table 8. Occlusion Devices Cardiology , by Region USD Million (2017-2022)
  • Table 9. Occlusion Devices Neurology , by Region USD Million (2017-2022)
  • Table 10. Occlusion Devices Peripheral Vascular , by Region USD Million (2017-2022)
  • Table 11. Occlusion Devices Urology , by Region USD Million (2017-2022)
  • Table 12. Occlusion Devices Oncology , by Region USD Million (2017-2022)
  • Table 13. Occlusion Devices Gyno , by Region USD Million (2017-2022)
  • Table 14. Occlusion Devices: by End-user(USD Million)
  • Table 15. Occlusion Devices Hospitals , by Region USD Million (2017-2022)
  • Table 16. Occlusion Devices Diagnostic Centers & Surgical Centers , by Region USD Million (2017-2022)
  • Table 17. Occlusion Devices ACCs , by Region USD Million (2017-2022)
  • Table 18. Occlusion Devices Research Laboratories , by Region USD Million (2017-2022)
  • Table 19. Occlusion Devices Academic Institutes , by Region USD Million (2017-2022)
  • Table 20. South America Occlusion Devices, by Country USD Million (2017-2022)
  • Table 21. South America Occlusion Devices, by Type USD Million (2017-2022)
  • Table 22. South America Occlusion Devices, by Application USD Million (2017-2022)
  • Table 23. South America Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 24. Brazil Occlusion Devices, by Type USD Million (2017-2022)
  • Table 25. Brazil Occlusion Devices, by Application USD Million (2017-2022)
  • Table 26. Brazil Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 27. Argentina Occlusion Devices, by Type USD Million (2017-2022)
  • Table 28. Argentina Occlusion Devices, by Application USD Million (2017-2022)
  • Table 29. Argentina Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 30. Rest of South America Occlusion Devices, by Type USD Million (2017-2022)
  • Table 31. Rest of South America Occlusion Devices, by Application USD Million (2017-2022)
  • Table 32. Rest of South America Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 33. Asia Pacific Occlusion Devices, by Country USD Million (2017-2022)
  • Table 34. Asia Pacific Occlusion Devices, by Type USD Million (2017-2022)
  • Table 35. Asia Pacific Occlusion Devices, by Application USD Million (2017-2022)
  • Table 36. Asia Pacific Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 37. China Occlusion Devices, by Type USD Million (2017-2022)
  • Table 38. China Occlusion Devices, by Application USD Million (2017-2022)
  • Table 39. China Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 40. Japan Occlusion Devices, by Type USD Million (2017-2022)
  • Table 41. Japan Occlusion Devices, by Application USD Million (2017-2022)
  • Table 42. Japan Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 43. India Occlusion Devices, by Type USD Million (2017-2022)
  • Table 44. India Occlusion Devices, by Application USD Million (2017-2022)
  • Table 45. India Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 46. South Korea Occlusion Devices, by Type USD Million (2017-2022)
  • Table 47. South Korea Occlusion Devices, by Application USD Million (2017-2022)
  • Table 48. South Korea Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 49. Taiwan Occlusion Devices, by Type USD Million (2017-2022)
  • Table 50. Taiwan Occlusion Devices, by Application USD Million (2017-2022)
  • Table 51. Taiwan Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 52. Australia Occlusion Devices, by Type USD Million (2017-2022)
  • Table 53. Australia Occlusion Devices, by Application USD Million (2017-2022)
  • Table 54. Australia Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 55. Rest of Asia-Pacific Occlusion Devices, by Type USD Million (2017-2022)
  • Table 56. Rest of Asia-Pacific Occlusion Devices, by Application USD Million (2017-2022)
  • Table 57. Rest of Asia-Pacific Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 58. Europe Occlusion Devices, by Country USD Million (2017-2022)
  • Table 59. Europe Occlusion Devices, by Type USD Million (2017-2022)
  • Table 60. Europe Occlusion Devices, by Application USD Million (2017-2022)
  • Table 61. Europe Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 62. Germany Occlusion Devices, by Type USD Million (2017-2022)
  • Table 63. Germany Occlusion Devices, by Application USD Million (2017-2022)
  • Table 64. Germany Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 65. France Occlusion Devices, by Type USD Million (2017-2022)
  • Table 66. France Occlusion Devices, by Application USD Million (2017-2022)
  • Table 67. France Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 68. Italy Occlusion Devices, by Type USD Million (2017-2022)
  • Table 69. Italy Occlusion Devices, by Application USD Million (2017-2022)
  • Table 70. Italy Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 71. United Kingdom Occlusion Devices, by Type USD Million (2017-2022)
  • Table 72. United Kingdom Occlusion Devices, by Application USD Million (2017-2022)
  • Table 73. United Kingdom Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 74. Netherlands Occlusion Devices, by Type USD Million (2017-2022)
  • Table 75. Netherlands Occlusion Devices, by Application USD Million (2017-2022)
  • Table 76. Netherlands Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 77. Rest of Europe Occlusion Devices, by Type USD Million (2017-2022)
  • Table 78. Rest of Europe Occlusion Devices, by Application USD Million (2017-2022)
  • Table 79. Rest of Europe Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 80. MEA Occlusion Devices, by Country USD Million (2017-2022)
  • Table 81. MEA Occlusion Devices, by Type USD Million (2017-2022)
  • Table 82. MEA Occlusion Devices, by Application USD Million (2017-2022)
  • Table 83. MEA Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 84. Middle East Occlusion Devices, by Type USD Million (2017-2022)
  • Table 85. Middle East Occlusion Devices, by Application USD Million (2017-2022)
  • Table 86. Middle East Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 87. Africa Occlusion Devices, by Type USD Million (2017-2022)
  • Table 88. Africa Occlusion Devices, by Application USD Million (2017-2022)
  • Table 89. Africa Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 90. North America Occlusion Devices, by Country USD Million (2017-2022)
  • Table 91. North America Occlusion Devices, by Type USD Million (2017-2022)
  • Table 92. North America Occlusion Devices, by Application USD Million (2017-2022)
  • Table 93. North America Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 94. United States Occlusion Devices, by Type USD Million (2017-2022)
  • Table 95. United States Occlusion Devices, by Application USD Million (2017-2022)
  • Table 96. United States Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 97. Canada Occlusion Devices, by Type USD Million (2017-2022)
  • Table 98. Canada Occlusion Devices, by Application USD Million (2017-2022)
  • Table 99. Canada Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 100. Mexico Occlusion Devices, by Type USD Million (2017-2022)
  • Table 101. Mexico Occlusion Devices, by Application USD Million (2017-2022)
  • Table 102. Mexico Occlusion Devices, by End-user USD Million (2017-2022)
  • Table 103. Occlusion Devices Sales: by Type(K Units)
  • Table 104. Occlusion Devices Sales Occlusion Balloon , by Region K Units (2017-2022)
  • Table 105. Occlusion Devices Sales Stent Retriever , by Region K Units (2017-2022)
  • Table 106. Occlusion Devices Sales Suction Device , by Region K Units (2017-2022)
  • Table 107. Occlusion Devices Sales Coil Embolization , by Region K Units (2017-2022)
  • Table 108. Occlusion Devices Sales Liquid Embolics , by Region K Units (2017-2022)
  • Table 109. Occlusion Devices Sales: by Application(K Units)
  • Table 110. Occlusion Devices Sales Cardiology , by Region K Units (2017-2022)
  • Table 111. Occlusion Devices Sales Neurology , by Region K Units (2017-2022)
  • Table 112. Occlusion Devices Sales Peripheral Vascular , by Region K Units (2017-2022)
  • Table 113. Occlusion Devices Sales Urology , by Region K Units (2017-2022)
  • Table 114. Occlusion Devices Sales Oncology , by Region K Units (2017-2022)
  • Table 115. Occlusion Devices Sales Gyno , by Region K Units (2017-2022)
  • Table 116. Occlusion Devices Sales: by End-user(K Units)
  • Table 117. Occlusion Devices Sales Hospitals , by Region K Units (2017-2022)
  • Table 118. Occlusion Devices Sales Diagnostic Centers & Surgical Centers , by Region K Units (2017-2022)
  • Table 119. Occlusion Devices Sales ACCs , by Region K Units (2017-2022)
  • Table 120. Occlusion Devices Sales Research Laboratories , by Region K Units (2017-2022)
  • Table 121. Occlusion Devices Sales Academic Institutes , by Region K Units (2017-2022)
  • Table 122. South America Occlusion Devices Sales, by Country K Units (2017-2022)
  • Table 123. South America Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 124. South America Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 125. South America Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 126. Brazil Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 127. Brazil Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 128. Brazil Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 129. Argentina Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 130. Argentina Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 131. Argentina Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 132. Rest of South America Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 133. Rest of South America Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 134. Rest of South America Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 135. Asia Pacific Occlusion Devices Sales, by Country K Units (2017-2022)
  • Table 136. Asia Pacific Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 137. Asia Pacific Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 138. Asia Pacific Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 139. China Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 140. China Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 141. China Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 142. Japan Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 143. Japan Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 144. Japan Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 145. India Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 146. India Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 147. India Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 148. South Korea Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 149. South Korea Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 150. South Korea Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 151. Taiwan Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 152. Taiwan Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 153. Taiwan Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 154. Australia Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 155. Australia Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 156. Australia Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 157. Rest of Asia-Pacific Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 158. Rest of Asia-Pacific Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 159. Rest of Asia-Pacific Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 160. Europe Occlusion Devices Sales, by Country K Units (2017-2022)
  • Table 161. Europe Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 162. Europe Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 163. Europe Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 164. Germany Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 165. Germany Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 166. Germany Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 167. France Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 168. France Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 169. France Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 170. Italy Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 171. Italy Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 172. Italy Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 173. United Kingdom Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 174. United Kingdom Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 175. United Kingdom Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 176. Netherlands Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 177. Netherlands Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 178. Netherlands Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 179. Rest of Europe Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 180. Rest of Europe Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 181. Rest of Europe Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 182. MEA Occlusion Devices Sales, by Country K Units (2017-2022)
  • Table 183. MEA Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 184. MEA Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 185. MEA Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 186. Middle East Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 187. Middle East Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 188. Middle East Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 189. Africa Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 190. Africa Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 191. Africa Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 192. North America Occlusion Devices Sales, by Country K Units (2017-2022)
  • Table 193. North America Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 194. North America Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 195. North America Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 196. United States Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 197. United States Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 198. United States Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 199. Canada Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 200. Canada Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 201. Canada Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 202. Mexico Occlusion Devices Sales, by Type K Units (2017-2022)
  • Table 203. Mexico Occlusion Devices Sales, by Application K Units (2017-2022)
  • Table 204. Mexico Occlusion Devices Sales, by End-user K Units (2017-2022)
  • Table 205. Occlusion Devices: by Type(USD/Units)
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Company Basic Information, Sales Area and Its Competitors
  • Table 215. Company Basic Information, Sales Area and Its Competitors
  • Table 216. Company Basic Information, Sales Area and Its Competitors
  • Table 217. Occlusion Devices: by Type(USD Million)
  • Table 218. Occlusion Devices Occlusion Balloon , by Region USD Million (2023-2028)
  • Table 219. Occlusion Devices Stent Retriever , by Region USD Million (2023-2028)
  • Table 220. Occlusion Devices Suction Device , by Region USD Million (2023-2028)
  • Table 221. Occlusion Devices Coil Embolization , by Region USD Million (2023-2028)
  • Table 222. Occlusion Devices Liquid Embolics , by Region USD Million (2023-2028)
  • Table 223. Occlusion Devices: by Application(USD Million)
  • Table 224. Occlusion Devices Cardiology , by Region USD Million (2023-2028)
  • Table 225. Occlusion Devices Neurology , by Region USD Million (2023-2028)
  • Table 226. Occlusion Devices Peripheral Vascular , by Region USD Million (2023-2028)
  • Table 227. Occlusion Devices Urology , by Region USD Million (2023-2028)
  • Table 228. Occlusion Devices Oncology , by Region USD Million (2023-2028)
  • Table 229. Occlusion Devices Gyno , by Region USD Million (2023-2028)
  • Table 230. Occlusion Devices: by End-user(USD Million)
  • Table 231. Occlusion Devices Hospitals , by Region USD Million (2023-2028)
  • Table 232. Occlusion Devices Diagnostic Centers & Surgical Centers , by Region USD Million (2023-2028)
  • Table 233. Occlusion Devices ACCs , by Region USD Million (2023-2028)
  • Table 234. Occlusion Devices Research Laboratories , by Region USD Million (2023-2028)
  • Table 235. Occlusion Devices Academic Institutes , by Region USD Million (2023-2028)
  • Table 236. South America Occlusion Devices, by Country USD Million (2023-2028)
  • Table 237. South America Occlusion Devices, by Type USD Million (2023-2028)
  • Table 238. South America Occlusion Devices, by Application USD Million (2023-2028)
  • Table 239. South America Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 240. Brazil Occlusion Devices, by Type USD Million (2023-2028)
  • Table 241. Brazil Occlusion Devices, by Application USD Million (2023-2028)
  • Table 242. Brazil Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 243. Argentina Occlusion Devices, by Type USD Million (2023-2028)
  • Table 244. Argentina Occlusion Devices, by Application USD Million (2023-2028)
  • Table 245. Argentina Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 246. Rest of South America Occlusion Devices, by Type USD Million (2023-2028)
  • Table 247. Rest of South America Occlusion Devices, by Application USD Million (2023-2028)
  • Table 248. Rest of South America Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 249. Asia Pacific Occlusion Devices, by Country USD Million (2023-2028)
  • Table 250. Asia Pacific Occlusion Devices, by Type USD Million (2023-2028)
  • Table 251. Asia Pacific Occlusion Devices, by Application USD Million (2023-2028)
  • Table 252. Asia Pacific Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 253. China Occlusion Devices, by Type USD Million (2023-2028)
  • Table 254. China Occlusion Devices, by Application USD Million (2023-2028)
  • Table 255. China Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 256. Japan Occlusion Devices, by Type USD Million (2023-2028)
  • Table 257. Japan Occlusion Devices, by Application USD Million (2023-2028)
  • Table 258. Japan Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 259. India Occlusion Devices, by Type USD Million (2023-2028)
  • Table 260. India Occlusion Devices, by Application USD Million (2023-2028)
  • Table 261. India Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 262. South Korea Occlusion Devices, by Type USD Million (2023-2028)
  • Table 263. South Korea Occlusion Devices, by Application USD Million (2023-2028)
  • Table 264. South Korea Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 265. Taiwan Occlusion Devices, by Type USD Million (2023-2028)
  • Table 266. Taiwan Occlusion Devices, by Application USD Million (2023-2028)
  • Table 267. Taiwan Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 268. Australia Occlusion Devices, by Type USD Million (2023-2028)
  • Table 269. Australia Occlusion Devices, by Application USD Million (2023-2028)
  • Table 270. Australia Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 271. Rest of Asia-Pacific Occlusion Devices, by Type USD Million (2023-2028)
  • Table 272. Rest of Asia-Pacific Occlusion Devices, by Application USD Million (2023-2028)
  • Table 273. Rest of Asia-Pacific Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 274. Europe Occlusion Devices, by Country USD Million (2023-2028)
  • Table 275. Europe Occlusion Devices, by Type USD Million (2023-2028)
  • Table 276. Europe Occlusion Devices, by Application USD Million (2023-2028)
  • Table 277. Europe Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 278. Germany Occlusion Devices, by Type USD Million (2023-2028)
  • Table 279. Germany Occlusion Devices, by Application USD Million (2023-2028)
  • Table 280. Germany Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 281. France Occlusion Devices, by Type USD Million (2023-2028)
  • Table 282. France Occlusion Devices, by Application USD Million (2023-2028)
  • Table 283. France Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 284. Italy Occlusion Devices, by Type USD Million (2023-2028)
  • Table 285. Italy Occlusion Devices, by Application USD Million (2023-2028)
  • Table 286. Italy Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 287. United Kingdom Occlusion Devices, by Type USD Million (2023-2028)
  • Table 288. United Kingdom Occlusion Devices, by Application USD Million (2023-2028)
  • Table 289. United Kingdom Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 290. Netherlands Occlusion Devices, by Type USD Million (2023-2028)
  • Table 291. Netherlands Occlusion Devices, by Application USD Million (2023-2028)
  • Table 292. Netherlands Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 293. Rest of Europe Occlusion Devices, by Type USD Million (2023-2028)
  • Table 294. Rest of Europe Occlusion Devices, by Application USD Million (2023-2028)
  • Table 295. Rest of Europe Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 296. MEA Occlusion Devices, by Country USD Million (2023-2028)
  • Table 297. MEA Occlusion Devices, by Type USD Million (2023-2028)
  • Table 298. MEA Occlusion Devices, by Application USD Million (2023-2028)
  • Table 299. MEA Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 300. Middle East Occlusion Devices, by Type USD Million (2023-2028)
  • Table 301. Middle East Occlusion Devices, by Application USD Million (2023-2028)
  • Table 302. Middle East Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 303. Africa Occlusion Devices, by Type USD Million (2023-2028)
  • Table 304. Africa Occlusion Devices, by Application USD Million (2023-2028)
  • Table 305. Africa Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 306. North America Occlusion Devices, by Country USD Million (2023-2028)
  • Table 307. North America Occlusion Devices, by Type USD Million (2023-2028)
  • Table 308. North America Occlusion Devices, by Application USD Million (2023-2028)
  • Table 309. North America Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 310. United States Occlusion Devices, by Type USD Million (2023-2028)
  • Table 311. United States Occlusion Devices, by Application USD Million (2023-2028)
  • Table 312. United States Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 313. Canada Occlusion Devices, by Type USD Million (2023-2028)
  • Table 314. Canada Occlusion Devices, by Application USD Million (2023-2028)
  • Table 315. Canada Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 316. Mexico Occlusion Devices, by Type USD Million (2023-2028)
  • Table 317. Mexico Occlusion Devices, by Application USD Million (2023-2028)
  • Table 318. Mexico Occlusion Devices, by End-user USD Million (2023-2028)
  • Table 319. Occlusion Devices Sales: by Type(K Units)
  • Table 320. Occlusion Devices Sales Occlusion Balloon , by Region K Units (2023-2028)
  • Table 321. Occlusion Devices Sales Stent Retriever , by Region K Units (2023-2028)
  • Table 322. Occlusion Devices Sales Suction Device , by Region K Units (2023-2028)
  • Table 323. Occlusion Devices Sales Coil Embolization , by Region K Units (2023-2028)
  • Table 324. Occlusion Devices Sales Liquid Embolics , by Region K Units (2023-2028)
  • Table 325. Occlusion Devices Sales: by Application(K Units)
  • Table 326. Occlusion Devices Sales Cardiology , by Region K Units (2023-2028)
  • Table 327. Occlusion Devices Sales Neurology , by Region K Units (2023-2028)
  • Table 328. Occlusion Devices Sales Peripheral Vascular , by Region K Units (2023-2028)
  • Table 329. Occlusion Devices Sales Urology , by Region K Units (2023-2028)
  • Table 330. Occlusion Devices Sales Oncology , by Region K Units (2023-2028)
  • Table 331. Occlusion Devices Sales Gyno , by Region K Units (2023-2028)
  • Table 332. Occlusion Devices Sales: by End-user(K Units)
  • Table 333. Occlusion Devices Sales Hospitals , by Region K Units (2023-2028)
  • Table 334. Occlusion Devices Sales Diagnostic Centers & Surgical Centers , by Region K Units (2023-2028)
  • Table 335. Occlusion Devices Sales ACCs , by Region K Units (2023-2028)
  • Table 336. Occlusion Devices Sales Research Laboratories , by Region K Units (2023-2028)
  • Table 337. Occlusion Devices Sales Academic Institutes , by Region K Units (2023-2028)
  • Table 338. South America Occlusion Devices Sales, by Country K Units (2023-2028)
  • Table 339. South America Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 340. South America Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 341. South America Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 342. Brazil Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 343. Brazil Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 344. Brazil Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 345. Argentina Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 346. Argentina Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 347. Argentina Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 348. Rest of South America Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 349. Rest of South America Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 350. Rest of South America Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 351. Asia Pacific Occlusion Devices Sales, by Country K Units (2023-2028)
  • Table 352. Asia Pacific Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 353. Asia Pacific Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 354. Asia Pacific Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 355. China Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 356. China Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 357. China Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 358. Japan Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 359. Japan Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 360. Japan Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 361. India Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 362. India Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 363. India Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 364. South Korea Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 365. South Korea Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 366. South Korea Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 367. Taiwan Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 368. Taiwan Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 369. Taiwan Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 370. Australia Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 371. Australia Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 372. Australia Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 373. Rest of Asia-Pacific Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 374. Rest of Asia-Pacific Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 375. Rest of Asia-Pacific Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 376. Europe Occlusion Devices Sales, by Country K Units (2023-2028)
  • Table 377. Europe Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 378. Europe Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 379. Europe Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 380. Germany Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 381. Germany Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 382. Germany Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 383. France Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 384. France Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 385. France Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 386. Italy Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 387. Italy Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 388. Italy Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 389. United Kingdom Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 390. United Kingdom Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 391. United Kingdom Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 392. Netherlands Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 393. Netherlands Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 394. Netherlands Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 395. Rest of Europe Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 396. Rest of Europe Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 397. Rest of Europe Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 398. MEA Occlusion Devices Sales, by Country K Units (2023-2028)
  • Table 399. MEA Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 400. MEA Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 401. MEA Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 402. Middle East Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 403. Middle East Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 404. Middle East Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 405. Africa Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 406. Africa Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 407. Africa Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 408. North America Occlusion Devices Sales, by Country K Units (2023-2028)
  • Table 409. North America Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 410. North America Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 411. North America Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 412. United States Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 413. United States Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 414. United States Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 415. Canada Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 416. Canada Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 417. Canada Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 418. Mexico Occlusion Devices Sales, by Type K Units (2023-2028)
  • Table 419. Mexico Occlusion Devices Sales, by Application K Units (2023-2028)
  • Table 420. Mexico Occlusion Devices Sales, by End-user K Units (2023-2028)
  • Table 421. Occlusion Devices: by Type(USD/Units)
  • Table 422. Research Programs/Design for This Report
  • Table 423. Key Data Information from Secondary Sources
  • Table 424. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Occlusion Devices: by Type USD Million (2017-2022)
  • Figure 5. Global Occlusion Devices: by Application USD Million (2017-2022)
  • Figure 6. Global Occlusion Devices: by End-user USD Million (2017-2022)
  • Figure 7. South America Occlusion Devices Share (%), by Country
  • Figure 8. Asia Pacific Occlusion Devices Share (%), by Country
  • Figure 9. Europe Occlusion Devices Share (%), by Country
  • Figure 10. MEA Occlusion Devices Share (%), by Country
  • Figure 11. North America Occlusion Devices Share (%), by Country
  • Figure 12. Global Occlusion Devices: by Type K Units (2017-2022)
  • Figure 13. Global Occlusion Devices: by Application K Units (2017-2022)
  • Figure 14. Global Occlusion Devices: by End-user K Units (2017-2022)
  • Figure 15. South America Occlusion Devices Share (%), by Country
  • Figure 16. Asia Pacific Occlusion Devices Share (%), by Country
  • Figure 17. Europe Occlusion Devices Share (%), by Country
  • Figure 18. MEA Occlusion Devices Share (%), by Country
  • Figure 19. North America Occlusion Devices Share (%), by Country
  • Figure 20. Global Occlusion Devices: by Type USD/Units (2017-2022)
  • Figure 21. Global Occlusion Devices share by Players 2022 (%)
  • Figure 22. Global Occlusion Devices share by Players (Top 3) 2022(%)
  • Figure 23. Global Occlusion Devices share by Players (Top 5) 2022(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 26. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 27. Boston Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 28. Boston Scientific (United States) Revenue: by Geography 2022
  • Figure 29. Cardinal Health (United States) Revenue, Net Income and Gross profit
  • Figure 30. Cardinal Health (United States) Revenue: by Geography 2022
  • Figure 31. Asahi Intecc (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Asahi Intecc (Japan) Revenue: by Geography 2022
  • Figure 33. Avinger (United States) Revenue, Net Income and Gross profit
  • Figure 34. Avinger (United States) Revenue: by Geography 2022
  • Figure 35. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 36. Medtronic (Ireland) Revenue: by Geography 2022
  • Figure 37. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 38. Terumo Corporation (Japan) Revenue: by Geography 2022
  • Figure 39. Stryker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 40. Stryker Corporation (United States) Revenue: by Geography 2022
  • Figure 41. Penumbra (United States) Revenue, Net Income and Gross profit
  • Figure 42. Penumbra (United States) Revenue: by Geography 2022
  • Figure 43. B. Braun (Germany) Revenue, Net Income and Gross profit
  • Figure 44. B. Braun (Germany) Revenue: by Geography 2022
  • Figure 45. C.R. Bard (United States) Revenue, Net Income and Gross profit
  • Figure 46. C.R. Bard (United States) Revenue: by Geography 2022
  • Figure 47. Global Occlusion Devices: by Type USD Million (2023-2028)
  • Figure 48. Global Occlusion Devices: by Application USD Million (2023-2028)
  • Figure 49. Global Occlusion Devices: by End-user USD Million (2023-2028)
  • Figure 50. South America Occlusion Devices Share (%), by Country
  • Figure 51. Asia Pacific Occlusion Devices Share (%), by Country
  • Figure 52. Europe Occlusion Devices Share (%), by Country
  • Figure 53. MEA Occlusion Devices Share (%), by Country
  • Figure 54. North America Occlusion Devices Share (%), by Country
  • Figure 55. Global Occlusion Devices: by Type K Units (2023-2028)
  • Figure 56. Global Occlusion Devices: by Application K Units (2023-2028)
  • Figure 57. Global Occlusion Devices: by End-user K Units (2023-2028)
  • Figure 58. South America Occlusion Devices Share (%), by Country
  • Figure 59. Asia Pacific Occlusion Devices Share (%), by Country
  • Figure 60. Europe Occlusion Devices Share (%), by Country
  • Figure 61. MEA Occlusion Devices Share (%), by Country
  • Figure 62. North America Occlusion Devices Share (%), by Country
  • Figure 63. Global Occlusion Devices: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Boston Scientific (United States)
  • Cardinal Health (United States)
  • Asahi Intecc (Japan)
  • Avinger (United States)
  • Medtronic (Ireland)
  • Terumo Corporation (Japan)
  • Stryker Corporation (United States)
  • Penumbra (United States)
  • B. Braun (Germany)
  • C.R. Bard (United States)
Additional players considered in the study are as follows:
Cook Group (United States) , Edwards Lifesciences (United States) , AngioDynamics, Inc. (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 246 Pages 65 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global (United States, European Union and China) Occlusion Devices Quantitative research analysis
Global (United States, European Union and China) Occlusion Devices Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increased Prevalence of Cardiovascular Diseases among People " is seen as one of major growth factors of Occlusion Devices Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Occlusion Devices market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global (United States, European Union and China) Occlusion Devices Report?

Have a Query? Click Here

Other Related Reports

Human Identification Comprehensive Study by Type (Lab Instruments, Lab Reagents and Chemicals, Kits and Assays, Software and Digital Storage, Others), Application (Offender DNA Data Basing, Forensic ...
$ 3750
Hearing Care Devices Comprehensive Study by Type (Hearing Aids, Hearing Implants), Application (Hospitals & Clinics, Home Settings, Ambulatory Surgical Centers (ASCs)), Type of Hearing Loss (Sensorin...
$ 3500
Surgical Microscopes Comprehensive Study by Type (On Caster, Wall Mounted, Table Top, Ceiling Mounted), Application (Neuro and Spine Surgery, Plastic and Reconstructive Surgery, Ear, Nose, and Throat...
$ 3650
Weight Loss Stomach Pump Comprehensive Study by Application (Clinics, Hospitals, Nursing Homes, Others), Disease Type (Anorexia, Bulimia, Diabetes, Others) Players and Region - Global Market Outlook ...
$ 3500
In Vitro Fertilization Device Comprehensive Study by Type (Dry Incubators, ICSI or IMSI, Centrifuge, Ovum Aspiration Pumps, Laser Hatching System, Cryo Cans, Embryoscope, Others), Application (Surgic...
$ 3800
Veterinary Endoscopy Comprehensive Study by Type (Flexible Endoscopy, Rigid Endoscopy, Robot Assisted Endoscopy), Application (Hospitals & Academic Institutes, Clinics), Procedure (Bronchoscopy, Lapa...
$ 3650